Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT05634967
Status:
RECRUITING
Last Update Posted:
2025-01-14
First Post:
2022-11-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Kesimpta (Ofatumumab) Pregnancy Registry
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2033-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-22
First Submit QC Date:
None
Study First Post Date:
2022-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-12
Last Update Post Date:
2025-01-14
Last Update Post Date Type:
ACTUAL